Novavax’s Post

Is it in Spanish?

The global vaccine drives of the second half of the 20th century are one of humanity’s greatest achievements. Vaccines save lifes, vaccines protects individuals and communities. We can make it possible for everyone to benefit from the life-saving power of vaccines!  https://lnkd.in/d8uDGABE  #worldimmunizationweek #immunizationforall #vaccineprotects #aşıkorur #bağışıklıksistemi #immünsistem #immunesystem #vaccinesprotectsyou #aşıhaftası

This is terrible but rather unsurprising news. I anticipate most will react to this by blaming vaccine hesitant people. But they are victims. Blame lies with coordinated antivax activist efforts, partisan media, and antivax-believing/pandering elected officials, among other bad actors. But less considered is how blame also extends to the underwhelming financial and other investments in promoting good science communication and public and patient education around vaccines. This includes efforts to prioritize research/interventions and form cross-sector coalitions, which, generally, have been disappointing as well as needlessly siloed and uncoordinated. The new pandemic age we have been in for several decades now absolutely requires that we act on this for the health and economic security of the US.

“Zero-dose children” Vaccination is one of the key preventive measures that any country can take to reduce their future disease burden, however, despite efforts by GAVI and other organizations, as of 2022, approximately 14.3 million children did not receive a single dose of life-saving vaccines (WHO 18 July 2023). They are referred to as Zero-dose children who are often found in areas affected by conflict, humanitarian emergencies, remote rural areas, and families living in poverty. These children are among the most vulnerable and are at high risk of vaccine-preventable diseases. Just under 60% of the 14.3 million zero-dose children live in 10 countries: Angola, Brazil, the Democratic Republic of the Congo, Ethiopia, India, Indonesia, Mozambique, Nigeria, Pakistan, and the Philippines. More efforts towards global health system strengthening and collaborations are required to address this gap.  

Vaccinating one child can protect an entire community. That's why Zipline and Gavi, the Vaccine Alliance have partnered up to improve public health by providing better access to routine childhood vaccines. Learn more in our 2023 Health Impact Report: https://lnkd.in/gG_C3b9F #GlobalHealth #Vaccines #PreventativeHealthcare #DroneDelivery #HealthcareAccess #ZiplineHealthImpact2023

Getting close now! Tick Tock. So dust-off your Barretinas, and join us at #WVCEU for some Winter Sun in Barcelona at Europe's premiere Vaccines event. We're expecting a record 3,000+ experts from across the globe. And if you're interested to learn and network with the industry's top executives, there's still time to get involved! Drop me a message at otto.squire@terrapinn.com to find out more. #VaccineDevelopment #VaccineInnovation #Vaccines #HealthcareInnovation

"Curious about the long-term side effects of COVID vaccines? Here's your chance to learn more! Join our conference to delve into this crucial topic and gain valuable insights. Register now: http://bit.ly/4aTUffp #Top_Vaccine_Conference_2024 #VaccineConferences #Virology_Meet #Euro_Vaccine_Conferences #COVIDVaccineSafety"

Vaccines have indeed revolutionized public health safety and security. They are by far the most cost-effective way of assuring the continued existence of all people worldwide. The role that Gavi has played in these efforts cannot be overemphasized, the time has come for all of us to secure our continued existence and create a much safer and more resilient world for our children and others yet unborn by investing in the public good with the best return on investment (ROI). Become an advocate and contributor to the Gavi replenishment drive and forever remain COUNTED # Vaccine saves lives

PCV20 FOR JAPANESE CHILDREN: CE STUDY This base scenario results suggested that vaccination with PCV20 prevented pneumococcal infections and deaths while incurring lower costs in comparison with PCV13 and PCV15. Therefore, PCV20, at the assumed acquisition cost of JPY 8,102, can be considered a dominant strategy over PCV13 and PCV15 from both the societal and payer perspectives, as it provides wider serotype coverage than lower-valent vaccines. The robustness of our base scenario results was further validated by scenario and sensitivity analyses.

Now it is accepted that #Covishield was a dirty vaccine. The truth of #COVID_19 #vaccine #Quality_Control was still dirtier, revealed through RTI (RTI CDSCO/R/E/21/00235) in 2021 by Dr. Sandeep Pahal, you may read details in  https://lnkd.in/dJ6KtT9m https://lnkd.in/dxXCcDrn    Now you know the #Reality of the #COVID19 vaccine, The COVID-19 vaccine acted as a #disease_causing_agent and was published in January 2021, but who cared? https://lnkd.in/gVi7m3cc https://lnkd.in/gBRSsBkz The Pros and Cons of COVID-19 Vaccines (Jan 2021) https://lnkd.in/grUiaHBP